Parenteral Drugs (India) Ltd - PARENTERAL DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE904D01019
₹ 2.90 (1.75%) icon21 Aug, 2023, 1:45:11 PM
Open
₹ 2.70
Prev. Close
₹ 2.85
Turnover(lac)
₹ 0.00
Day's High
₹ 2.90
Day's Low
₹ 2.70
52 Wk High
₹ 3.80
52 Wk Low
₹ 2.70
Book Value
₹ -290.46
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 8.65
P/E
0.00
EPS
0.00
Div. Yield
0.00

Parenteral Drugs (India) Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 8/21/2023 1:45:11 PM

    ₹ 2.9 0.05 1.75
  • Open
  • ₹ 2.7
  • Prev. Close
  • ₹ 2.85
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 2.9
  • Day's Low
  • ₹ 2.7
  • 52 Week's High
  • ₹ 3.8
  • 52 Week's Low
  • ₹ 2.7
  • Book Value
  • ₹ -290.46
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 8.65
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Parenteral Drugs (India) Ltd Corporate Actions

No Record Found


Parenteral Drugs (India) Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Parenteral Drugs (India) Ltd SHAREHOLDING SNAPSHOT
18 April , 2024 | 06:55 PM

PROMOTER - TOTAL73.29%

Indian: 73.29%

Foreign: 0%

NON-PROMOTER - TOTAL 26.71%

Institutions: 0.01%

Non-Institutions: 26.71%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Parenteral Drugs (India) Ltd FINANCIALS

Parenteral Drugs (India) Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Parenteral Drugs (India) Ltd

  • Manoharlal Gupta
  • Chairman
  • Govind Das Garg
  • Whole-time Director
  • Dharam Pal Khanna
  • Independent Director
  • Dilip Kumar Sinha
  • Independent Director
  • Anil Mittal
  • Non Executive Director
  • Manish Verma
  • Independent Director
  • Vinod Kumar Gupta
  • Managing Director & CFO
  • Deepali Garhewal
  • Independent Director
  • Chhaya Gupta
  • Independent Director

Summary

Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company. In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum. In March 1994, the company was converted into a public limited company. Parenteral Drugs (India) is an India-based pharmaceutical company. The Company manufactures, and markets pharmaceutical products in India, including solid and liquid orals, such as antibiotics and anti-bacterial, anti-ulcerant, analgesics/anti-inflammatory, multivitamins and minerals, anxiolyic , antiprotozoal, anticold, anthelmintic, anti-histaminic, muscle relaxant, cardiac, antidiabetic, cough syrup, appetite enhancer and injections. The Company produces various therapeutic segments of In-Vitro (I V) Fluids, such as electrolytes, antibacterial, energy replenisher, irrigation solution, osmotic diuretic, dialysis solution. They produce 400-milligram Ciprofloxacin infusion in 200 milliliter with 5% dextose. Apart from the single dose dispensers, the Company launched multi-dose eye/ ear drops in plastic containers. The dispensers are made using the form-fill-seal technology.In September 1994, the Company came out with a Public Issue at a premium of Rs 80, aggregating Rs 7.03 crore, to part-finance their Rs 8.97 Cr. expansion. During the year 1994-95, the Company set up a joint venture unit in Ukraine for manufacture of a wide range of pharmaceuticals. In addition, they... Read More


Reports by Parenteral Drugs (India) Ltd


Reports by Parenteral Drugs (India) Ltd

Company FAQ

No Record Found